
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 1803171-55-2 | 货号 | BCP46121 |
中文名 | 雷夫利珠单抗 | ||
英文名 | Ravulizumab | ||
中文别名 | |||
英文别名 | ALXN-1210;ALXN1210; | ||
SMILES | |||
化学名称 | |||
分子式 | 分子量 | ||
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Ravulizumab, a humanized monoclonal antibody that binds with high affinity to complement protein C5 and inhibits terminal complement activation, is being evaluated as a treatment for COVID-19-related severe pneumonia, acute lung injury, and acute respiratory distress syndrome in an ongoing phase 3 randomized controlled trial (ALXN1210-COV-305). |
相关产品推荐
查看更多 >Tags:Ravulizumab 供应商,Ravulizumab 购买,Ravulizumab 生产,Ravulizumab 批量,Ravulizumab 供应,Ravulizumab 订购,Ravulizumab 采购